TRV GP III’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

TRV GP III’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-680,272	Closed	-$33.2M	–	4
2018 Q1	$33.2M	Sell	680,272 -816,326	-55%	-$42.4M	11.95%	3
2017 Q4	$63M	Buy	+1,496,598	New	+$57.7M	22.06%	2

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

TRV GP III's MYOK Position: Q2 2018 in Review

TRV GP III sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2018, closing a stake of 680,272 shares — an estimated $33.2M sold.

TRV GP III first reported a position in MYOK in Q4 2017 and held it in 2 quarters. The position peaked at $63M in Q4 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q2 2018.

TRV GP III reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
TRV GP III sold 680,272 MyoKardia, Inc. Common Stock shares in Q2 2018, an estimated $33.2M.
TRV GP III first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
TRV GP III's MyoKardia, Inc. Common Stock position peaked at $63M in Q4 2017.
121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2018.

Based on TRV GP III's 13F filing for Q2 2018, filed 7 Aug 2018.